Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety
<p>Abstract</p> <p>Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily...
Main Authors: | Papadimos Thomas J, Grum Daniel F, Fahed Samir |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-05-01
|
Series: | Patient Safety in Surgery |
Online Access: | http://www.pssjournal.com/content/2/1/13 |
Similar Items
-
Hypotension and bradycardia before spinal anesthesia
by: Carlos Javier Shiraishi Zapata
Published: (2017-09-01) -
Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient
by: Carmen Fierro, et al.
Published: (2021-01-01) -
Sugammadex associated profound bradycardia and sustained hypotension
by: Jae Moon Choi, et al.
Published: (2020-01-01) -
Bradycardia, Hypotension, and Midventricular Takotsubo Syndrome during Esophagogastroduodenoscopy
by: John E. Madias
Published: (2016-05-01) -
Comparison of labetalol and lidocaine in induction of controlled hypotension in tympanoplasty: a randomized clinical trial
by: Ali Karami, et al.
Published: (2024-05-01)